Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03233646 · ClinicalTrials.gov registry record

Retinal Imaging in Neurodegenerative Disease

A clinical trial of Multiple Sclerosis and Mild Cognitive Impairment, sponsored by Duke University.

Recruiting
Registry status
2,000
Enrollment target
1
Study location

NCT03233646 is a study of Multiple Sclerosis and Mild Cognitive Impairment that is actively recruiting participants, run by Duke University. The registered enrollment target is 2,000 participants, above the 579-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03233646, a study of Multiple Sclerosis and Mild Cognitive Impairment, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
2,000 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield (UWF) fundus photography to assess the structure and function of the retinal and choroidal microvasculature and structure in persons with mild cognitive impairment (MCI) and Alzheimer's Disease (AD), Parkinson's Disease (PD), or other neurodegenerative disease, diseases as outlined.

Conditions Studied

Multiple Sclerosis Mild Cognitive Impairment Traumatic Brain Injury Parkinson's Disease Alzheimers Disease Huntington Disease Frontotemporal Dementia Amyotrophic Lateral Sclerosis (ALS) Lewy Body Dementia APOE-4 Positive

Interventions

  • DEVICE Retinal and Choroidal Imaging

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2017-07-20
Est. Completion 2026-12-31

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03233646

The ClinicalTrials.gov registry entry for NCT03233646 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 579-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (245% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Retinal and Choroidal Imaging is the first listed.

NCT03233646 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03233646 about?

NCT03233646 is a clinical study titled "Retinal Imaging in Neurodegenerative Disease". This study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield (UWF) fundus photography to assess the structure and function of the retinal and choroidal microvasculature and structure in persons with mil...

What is the current status of trial NCT03233646?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2017-07-20. Estimated completion is 2026-12-31.

What conditions does trial NCT03233646 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Mild Cognitive Impairment, Traumatic Brain Injury, Parkinson's Disease, Alzheimers Disease.

What interventions are being tested in trial NCT03233646?

The interventions under investigation include: Retinal and Choroidal Imaging (DEVICE).

Who is sponsoring clinical trial NCT03233646?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03233646 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Mild Cognitive Impairment

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.